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Abstract
Background: The placenta plays an important role in the control of in utero HIV-1 mother-to-child
transmission (MTCT). Proinflammatory cytokines in the placental environment are particularly
implicated in this control. We thus investigated the effect of TNF-α on HIV-1 expression in human
placental tissues in vitro.
Results: Human placental chorionic villi fragments were infected with varying doses of luciferase
reporter HIV-1 pseudotypes with the R5, X4-Env or the vesicular stomatitis virus protein G (VSV-
G). Histocultures were then performed in the presence or absence of recombinant human TNF-α. Luciferase activity was measured at different time points in cell lysates or on whole fragments
using ex vivo imaging systems.
A significant increase in viral expression was detected in placental fragments infected with 0.2 ng of
p24 antigen/fragment (P = 0.002) of VSV-G pseudotyped HIV-1 in the presence of TNF-α seen after
120 hours of culture. A time independent significant increase of viral expression by TNF-α was
observed with higher doses of VSV-G pseudotyped HIV-1. When placental fragments were infected
with R5-Env pseudotyped HIV-1, a low level of HIV expression at 168 hours of culture was
detected for 3 of the 5 placentas tested, with no statistically significant enhancement by TNF-α.
Infection with X4-Env pseudotyped HIV-1 did not lead to any detectable luciferase activity at any
time point in the absence or in the presence of TNF-α.
Conclusion: TNF-α in the placental environment increases HIV-1 expression and could facilitate
MTCT of HIV-1, particularly in an inflammatory context.
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Background
In utero transmission of the human immunodeficiency
virus type 1 (HIV-1) is one of the routes through which
infants acquire HIV-1 from their mothers [1]. However,
the placenta forms an efficient barrier between maternal
and foetal circulations and plays a crucial role in the regu-
lation of mother-to-child transmission (MTCT) of HIV-1.
The trophoblasts are the placental cells in direct contact
with maternal circulation. It has been observed that trans-
mission of HIV-1 between T lymphocytes and trophob-
lasts is possible [2,3] and that cell-to-cell contact between
HIV-1 infected peripheral blood mononuclear cells
(PBMCs) and cells of trophoblast origin led to the passage
of virus from the apical to the basolateral side of a tro-
phoblast barrier reconstituted in vitro [4]. Soluble factors
such as RANTES and MIP-lβ decrease viral passage
through this placental trophoblast barriers inoculated
with HIV-1 infected cells while TNF-α and IL-8 increase it
[5].
On the other hand, isolated primary trophoblasts or
malignantly transformed human cell lines of trophoblast
lineage are highly resistant to infection with cell-free HIV-
1 particles. This resistance has been shown to be bypassed
when HIV-1 envelope are substituted by the vesicular-sto-
matitis virus G protein in the HIV-1 pseudotypes used to
infect trophoblast cells [6]. Vidricaire and colleagues
observed that cell-free viruses are able to enter with high
efficiency into trophoblast cell lines [7]. However viral
entry is mediated in large part through endosomal vesicles
which ends up in the degradation of a majority of these
viral particles but the initial presence of HIV-1 within the
endosomes seems to be mandatory for infection to take
place in these cells [8]. Production of fully infectious HIV-
1 particles by trophoblast cells was only seen following
treatment with TNF-α or IL-1 and subsequent co-culture
with indicator cells bearing a reporter gene. This con-
firmed a previous study showing that cytokines, notably
TNF-α, stimulate replication of HIV-1 in trophoblast cells
[9].
Few studies have been carried out on term placental tissue
ex vivo [10]. Maury et al. showed that term placental tissue
can support a low HIV-1 replication when infected with
cell-free laboratory viral strain used at high doses and after
coculture with indicator PBMCs. No study to the best of
our knowledge addressed the effect of TNF-α on HIV-1
replication within the placental tissue. Since TNF-α is
known to be expressed in the placenta environment espe-
cially during viral [11,12] or parasitic infections [13,14],
HIV-1 placental tissue infection was studied in the pres-
ence or absence of recombinant human TNF-α using the
placental histoculture system recently described [14] and
a single-cycle viral replication system.
Results
Placental histocultures replicate VSV-G pseudotyped HIV-
1 in a time and viral dose dependent manner in the 
absence of TNF-α stimulation
As shown on Table 1, only background level of luciferase
activity was detected after 48, 96 and 120 h of histoculture
when the envelope deficient (delta-Env) pseudotyped
HIV-1 was used.
When placental fragments were infected by the VSV-G
pseudotyped HIV-1, a dose dependent replication was
observed with an increase of luciferase activity overtime.
At the lowest dose of VSV-G pseudotyped HIV-1 used (0.2
ng of p24 antigen/placental fragment), after an increase at
96 h, the luciferase activity dropped at 120 h. In contrast
with higher doses, the increase remained up to 120 h.
No luciferase activity was observed in preliminary results
obtained after infection kinetics of placental fragments
(48–120 h post infection) with R5 and X4 pseudotyped
HIV-1 despite the fact that control cells (HeLa P4P) were
highly infected by both pseudotypes (Figure 1). We there-
Table 1: Hiv-1 pseudotype replication in the human placental histoculture system in the absence of TNF-α stimulation
Luciferase Activity (Relative Light Units/mn): mean (SE), n
Time post-infection: 48 h 96 h 120 h 168 h 216 h
HIV-1/Delta-Env (20 ng*) 2,660 (356), 3 3,300 (1,637), 3 2,830 (911), 6
HIV-1/VSV-G (0.2 ng*) 4,010 (1,224), 3 14,110 (9,591),3 5,420 (4,152), 3
HIV-1/VSV-G (2 ng*) 14,520 (16,718), 3 77,880 (22,016), 3 93,640 (34,095), 7
HIV-1/VSV-G (20 ng*) 213,190 (195,249), 3 1,266,430 (449,346), 
3
1,397,280 (861,789), 
3
HIV-1/Ba-L (20 ng*) 2,562 (312), 6 2,535 (475), 5 2,670 (286), 4
HIV-1/Ba-L (50 ng*) 3,830 (3,612), 6 10,380 (7,478), 5 2,625 (772), 4
HIV-1/HXB2 (50 ng*) 2,620 (827), 3 3,010 (135), 3 2,210 (399), 3
HIV-1/HXB2 (100 ng*) 2,950 (458), 3 2,860 (255), 3 2,580 (1,046), 3
* : of p24 antigen
Retrovirology 2006, 3:36 http://www.retrovirology.com/content/3/1/36
Page 3 of 9
(page number not for citation purposes)
fore left placental fragments after overnight contacts with
R5 and X4 pseudotyped viruses in culture for longer peri-
ods (120–216 h post infection). For the R5 envelope
pseudotyped HIV-1, a modest increase of replication was
observed at 168 h post infection at the highest concentra-
tion used (50 ng of p24 antigen/placental fragment) for 3
placentas out of 5 tested in the whole range of kinetics.
These data show that despite the extended culture periods,
the placental fragments remained resistant to infection
with HIV-1 pseudotypes bearing X4 (HXB2) envelopes
even at concentration as high as 100 ng of p24 antigen/
placental fragment. It should be noted that the very same
placentas were readily infected by the HIV-1 pseudotype
bearing the VSV-G envelope.
TNF-α significantly increases the replication of VSV-G 
pseudotyped HIV-1 in placental histocultures
In all experimental conditions, the dose effect of TNF-α (5
vs 50 ng/ml) did not vary with the duration of histocul-
ture (absence of interaction between TNF-α and duration
of histoculture) and TNF-α effect was homogeneous
across doses. Therefore, the TNF-α effect is presented glo-
bally as mean ratio, whatever the TNF-α dose used.
When the envelope deficient (delta-Env) pseudotyped
HIV-1 was used, luciferase activity was not modified by
TNF-α after 48, 96 and 120 h of histoculture duration (mR
of 1.16 ± 0.20, p = 0.45) (Figure 2D).
For the lowest dose of VSV-G pseudotyped HIV-1 (0.2 ng
of p24 antigen/placental fragment), the effect of TNF-α on
the viral replication was highly significant with a mR of
4.59 ± 0.91 (p = 0.002) after 120 hours postinfection and
was not observed at earlier time points with a mR of 1.04
and 1.01 after 48 and 96 h, respectively (Figure 2A). At
higher viral doses, 2 and 20 ng of p24 antigen/placental
fragment, an increase of viral replication was observed in
the presence of TNF-α with a global mR of 2.19 ± 0.28 (p
= 0.001, Figure 2B) and 1.41 ± 0.19 (p = 0.05, Figure 2C),
respectively. For the other pseudotypes tested, R5 (Figure
3A and 3B) or X4 (Figure 3C and 3D) envelope pseudo-
typed HIV-1, TNF-α did not significantly increase the viral
replication in the placental histocultures, whatever the
time point or the viral dose used, with a global mR of 1.08
± 0.14 (p = 0.56) and 1.11 ± 0.07 (p = 0.15), respectively.
With the Xenogen system, infection with the VSV-G pseu-
dotyped HIV-1 was also detected, demonstrated by an
increase in the bioluminescence emitted from placental
fragments stimulated with TNF-α compared to those
without TNF-α treatment. In a representative case shown
in Figure 4, bioluminescence values without TNF-α were
31,501 photons/sec, and 93,449 photons/sec with 5 ng/
ml of TNF-α. Using this system, we observed that not all
placental fragments were detectably infected with the
VSV-G pseudotyped HIV-1 despite the fact that they all
underwent the same treatments. No bioluminescence was
detected in the xenogen system when the delta-Env pseu-
dotyped HIV-1 was used with or without TNF-α stimula-
tion.
Discussion
This study demonstrates the fact that human term placen-
tal chorionic villi can be infected and stimulated to repli-
cate HIV-1 when VSV-G pseudotyped HIV-1 is used. When
R5-Env pseudotyped HIV-1 is used, a low level of transient
infection can be detected for some of the placentas tested.
In contrast when X4-Env pseudotyped HIV-1 is used, no
infection is detected.
Titration of Ba-L and HXB2 pseudotyped HIV-1 on HeLa P4P cellsF gure 1
Titration of Ba-L and HXB2 pseudotyped HIV-1 on 
HeLa P4P cells. 104 HeLa P4P cells/well/100 µl were 
seeded in 96 flat-bottomed well plates. Infections were per-
formed 24 hours later. Cells were lysed 72 hours post infec-
tion with 100 µl of lysis buffer (Promega, Madison USA). 100 µl of commercially available luciferase substrate (Promega, 
Madison, USA) were added to 20 µl of each lysate and then 
luciferase activity read with a luminometer (Lumat LB 9501, 
Berthold) as relative light units (RLU) per minute. A: Ba-L 
pseudotyped HIV-1; B: HXB2 pseudotyped HIV-1.
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Previous studies have shown that malignantly trans-
formed human cell lines of the trophoblast lineage are
resistant to cell-free HIV-1 pseudotypes bearing the R5
and X4 envelopes [6]. In this study we demonstrate that
the human placental chorionic villi are not permissive to
X4-Env pseudotyped HIV-1 and display limited permis-
sivity to R5-Env pseudotyped HIV-1 as exemplified by the
low luciferase activity values observed even in the pres-
ence of the highest dose of TNF-α. This lack of activation
of the HIV-1 replication with TNF-α contrasts with the
results obtained with choriocarcinoma cell lines by Vidric-
aire and colleagues who reported an increase of luciferase
activity in these cells after infection with R5 or X4-Env
pseudotyped HIV-1 in the presence of TNF-α [7]. These
apparent contradictory findings might be explained by
different experimental conditions. Our study was per-
formed on human term placental tissue and not on cell
lines. R5 or X4-Env pseudotyped HIV-1 viruses were used
in a dose range of 20 to 100 ng of p24 antigen to infect
human placental fragments in contrast to the 250 to 400
ng of p24 antigen used by Vidricaire and colleagues to
infect cells. Finally in our experiments, the TNF-α treated
placental fragments were not co-cultured with indicator
cells to amplify replication because we used non produc-
tive single-cycle replicating viral pseudotypes.
The fact that 3 placentas out of 5 were modestly and tran-
siently infected by R5-Env pseudotyped HIV-1 might have
some biological relevance in the context of HIV-1 MTCT.
Indeed, HIV-1 MTCT occurs mainly with R5 viruses. Addi-
Infection with VSV-G or delta-Env pseudotyped HIV-1 of placental chorionic villi in the absence or presence of TNF-αFigure 2
Infection with VSV-G or delta-Env pseudotyped HIV-1 ofplacental chorionic villi in the absence or presence of 
TNF-α. Viral pseudotypes were left in contact with placental fragments overnight. After viral contact, fragments were cultured 
in medium supplemented with (grey histograms) or without (horizontal black line) TNF-α and cultures stopped at 48, 96, 120 
hours post-infection. Fragments were homogenized and luciferase activity read from tissue lysate. Results are presented as 
ratio (mean ± SE) of luciferase activity with TNF-α stimulation to activity without stimulation in three to seven (n) placentas 
from different donors. A: VSV-G pseudotyped HIV-1 at 0.2 ng of p24/placental fragment; B: VSV-G pseudotyped HIV-1 at 2 ng 
of p24/placental fragment; C: VSV-G pseudotyped HIV-1 at 20 ng of p24/placental fragment; D: delta-Env pseudotyped HIV-1 at 
20 ng of p24/placental fragment.
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tionally, 5–10% of infants born to HIV infected mothers
are infected in utero in the absence of any prophylaxis
[15]. Thus, there might be a difference in the susceptibility
of some placentas to cell-free R5 virus infection and trans-
mission.
The chorionic villi are made up of several cell types such
as syncytiotrophoblasts, cytotrophoblasts, Hofbauer cells
and stromal cells which has been shown to express varia-
ble levels of surface CD4, CXCR4 and CCR5 [16-19]. The
expression of CD4 on the surface of trophoblasts is still a
matter of debate, however even if they express CD4, they
do not produce detectable viral particles when infected
with fully competent infectious cell-free viruses [6].
A dose dependent infection was observed with VSV-G
pseudotyped HIV-1 whose replication is increased by
TNF-α. This implies that TNF-α would increase viral repli-
cation in the placenta when the initial resistance to cell-
free HIV-1 infection in vivo is bypassed, after cell-to-cell
infection for example. In fact, proinflammatory cytokines
such as TNF-α and IL-8 have been shown to increase viral
replication in different cell lines, isolated primary cells or
cervical explant tissue [9,5,20]. Indeed, in our study, TNF-
Infection with R5 or X4 envelope pseudotyped HIV-1 of placental chorionic villi in the absence or presence of TNF-αFigure 3
Infection with R5 or X4 envelope pseudotyped HIV-1 of placental chorionic villi in the absence or presence of 
TNF-α. Viral pseudotypes were left in contact with placental fragments overnight. After viral contact, fragments were cultured 
in medium supplemented with (grey histograms) or without (horizontal black line) TNF-α and cultures stopped at 120, 168 or 
216 hours post-infection. Fragments were homogenised and luciferase activity read from tissue lysate. Results are presented as 
ratio (mean ± SE) of luciferase activity with TNF-α stimulation to activity without stimulation in three to seven (n) placentas 
from different donors. A: R5 (Ba-L) pseudotyped HIV-1 at 20 ng of p24/placental fragment; B: R5 (Ba-L) pseudotyped HIV-1 at 
50 ng of p24/placental fragment; C: X4 (HXB2) pseudotyped HIV-1 at 50 ng of p24/placental fragment; D: X4 (HXB2) pseudo-
typed HIV-1 at 100 ng of p24/placental fragment.
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α appeared to be capable of stimulating HIV-1 replication
in term placental chorionic villi with the various cell sub-
populations present. It should be recalled here that VSV-G
pseudotyped HIV-1 are able to infect any cell type, regard-
less of receptor and coreceptor surface expression, due to
its amphotropic nature. It has been previously described
that the mechanisms by which TNF-α enhance HIV-1 rep-
lication occurred via the NF-kB pathway [21]. TNF-α acti-
vates HIV-1 LTR-driven transcriptional activity in
choriocarcinoma cell line [7] and isolated primary tro-
phoblast cells [9]. Such a mechanism might also occur in
placental chorionic villi. The fact that the TNF-α stimula-
tion of HIV-1 replication is not dependent of the dose
tested (5 and 50 ng/ml) is consistent with a recent finding
demonstrating that the temporal profile of the NF-kB
activity is invariant to a wide range of TNF-α doses going
from 0.01 ng/ml up to 10 ng/ml [22].
It should be noted that the TNF-α effect is time and VSV-
G pseudotyped HIV-1 concentration dependent. Hence, at
0.2 ng of p24 antigen of VSV-G pseudotyped HIV-1/frag-
ment, the increase of replication by TNF-α is only
observed at 120 h post-infection whatever the cytokine
concentration. At 2 ng of p24 antigen of VSV-G pseudo-
typed HIV-1/fragment, the effect of TNF-α is only signifi-
cant when data were analyzed globally for all the time
points tested whereas at 20 ng of p24 antigen/fragment,
the TNF-α effect is barely significant due to an already
high basal replication without TNF-α (Table 1).
Furthermore, as shown by the Xenogen system (Figure 4),
not all the placental fragments from the same experimen-
tal wells were infected with VSV-G-pseudotyped HIV-1 to
detectable levels even in the presence of TNF-α. This sug-
gests that the susceptibility to infection is not homogene-
ous for all the chorionic villi from a given placenta and
thus explains the high variability observed between pla-
centas. However, we cannot exclude that this non homo-
geneous infection is also due to the non saturating dose of
pseudotypes used for this experiment. This result might
also explain why there was no detectable stimulation of
luciferase activity in the presence of TNF-α with the R5-
Env pseudotyped HIV-1 while there was a modest and
transient infection.
Altogether, these results highlight the subtle equilibrium
between the viral load, the timing of cytokine expression
and the regulation of viral replication within the placenta
that might ultimately influence HIV-1 MTCT.
The demonstration that TNF-α could enhance HIV-1 rep-
lication in the placental tissue is important, since a shift in
cytokine production towards a proinflammatory profile
(notably TNF-α) has been associated with Plasmodium fal-
ciparum placental infections. [23,24,13]. This is of partic-
ular public health concern in regions of the world where
HIV-1 and malaria are both endemic. Malaria has been
shown to reach peak transmission periods during the rain-
ing seasons [25]. In an earlier work, a peak in HIV-1 MTCT
was reported three months after the peaks of the rains in
Cameroon [26], suggesting that the observed increase in
HIV-1 MTCT could have been due to an increase of TNF-α in the placental environment as a result of malaria. The
present study showing an increase of HIV-1 replication by
TNF-α within the placental tissue supports this hypothe-
sis. However direct evidence are still required before we
can conclude that placental malaria is linked with an
increase transmission of HIV-1 from mother-to-child via
an increase of placental proinflammatory cytokines. As
discussed in a recent review, several published studies
show no, little or significant association of malaria with
HIV-1 MTCT [27]. Some studies done on cohorts of preg-
nant women found no correlation between placental
malaria and in utero HIV-1 MTCT [28]. Others studies
have demonstrated that the effects of malaria on HIV-1
MTCT depends on placental malaria parasitemia [29].
Ex vivo bioluminescence imaging of HIV-1 infected placental chori nic villi stimulated or not with TNF-αFigure 4
Ex vivo bioluminescence imaging of HIV-1 infected 
placental chorionic villi stimulated or not with TNF-α. Placental chorionic villi were placed in contact with pseu-
dotyped HIV-1 overnight. After the addition of luciferine for 
4 h at 37°C, the tissues were analysed with the Xenogen sys-
tem. Infection of chorionic villi with 2 ng of p24/fragment of 
VSV-G pseudotyped HIV-1 in the absence (well 1) or pres-
ence of 5 ng/ml of TNF-α (well 3). Infection of chorionic villi 
with 20 ng of p24/fragment of delta-Env pseudotyped HIV-1 
in the absence (well 2) or presence of 5 ng/ml of TNF-α (well 
4).
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Conclusion
In summary, data presented here show, by using a single-
cycle replication system, that TNF-α enhances HIV-1 rep-
lication in chorionic villi of the human placental tissue
once viral entry is overcome, as seen with the VSV-G pseu-
dotyped HIV-1. This implies that in vivo TNF-α would
increase viral replication in the placenta when the initial
resistance to cell-free HIV-1 infection is bypassed, after
cell-to-cell infection for example. Altogether, these results
highlight the subtle equilibrium within the placental envi-
ronment between the viral load, the timing of proinflam-
matory cytokine expression and the regulation of viral
replication that might ultimately influence HIV-1 MTCT.
Methods
Placenta collection and preparation
Term placentas from HIV-1 negative women were col-
lected in accordance with French ethical guidelines after
programmed caesarean section at the Antoine Béclère
(Clamart, France) and Robert Debré (Paris, France) hospi-
tals. Placentas were processed within 2 to 3 hours follow-
ing collection to isolate chorionic villi. After extensive
washes with normal medium (RPMI-1640 supplemented
with 10% heat-inactivated fetal calf serum (FCS), 1% L-
Glutamine and 1% Penicillin/Streptomycin), each pla-
centa was cut to obtain several villi blocks of 2 to 3 mm.
Blocks were then distributed in 12-well plates, nine villi
blocks per well, and in triplicate wells. For each placenta,
63 to 144 blocks were prepared.
Viral pseudotype preparation and infection of placental 
fragments
Luciferase reporter viruses were prepared as previously
described [6], by co-transfecting 293T cells with the NL4-
3 luciferase virus backbone (pNL-Luc E-R-) and VSV-G or
HIV-1 R5 (Ba-L) or X4 (HXB2) env plasmids, with the aid
of SuperFect (Qiagen, France). Each pseudotype prepara-
tion was tested for effective infection at different concen-
trations on HeLa P4P. Briefly, 104 cells/well/100 µl were
seeded in 96 flat-bottomed well plates. Infections were
performed 24 hours later. Cells were lysed 72 hours post
infection with 100 µl of lysis buffer (Promega, Madison,
WI, USA). 100 µl of commercially available luciferase sub-
strate (Promega) were added to 20 µl of each lysate and
then luciferase activity read with a luminometer (Lumat
LB 9501, Berthold) as relative light units (RLU) per
minute.
Different concentrations of the various viral pseudotypes
in histoculture medium (RPMI 1640 supplemented with
1% Penicillin/Streptomycin, 1% L-Glutamine, 15% FCS,
0.1% gentamycin, 1% Fungizone, 1% non-essential
amino acids, 1% sodium pyruvate -all from Gibco BRL
Ltd, Paisley, Scotland, UK) were left in contact with the
placental fragments in triplicate wells. Each set of tripli-
cate placental wells contained one of the following pseu-
dotype doses: 0.2 ng, 2 ng and 20 ng of p24 antigen/
fragment of VSV-G-pseudotyped HIV-1, 20 ng and 50 ng
of p24 antigen/fragment of R5-Env pseudotyped HIV-1
(Ba-L), 50 ng and l00 ng of p24 antigen/fragment of X4-
Env pseudotyped HIV-1 (HXB2) and 20 ng of p24 antigen
of the envelope deficient pseudotype (delta-Env pseudo-
typed HIV-1) used as a negative control for infection. All
contacts were left overnight at 37°C in a 5% CO2 incuba-
tor.
Placental histocultures and TNF-α stimulation
After overnight contact, the nine villi blocks from each
well were transferred into 70 µm nylon cell strainers (BD
Bioscience, Belgium) and rinsed three times in PBS
(Gibco BRL Ltd, Paisley, Scotland, UK). As previously
described [14], the villi blocks from each set of triplicate
wells were then placed on collagen sponge gels (Pharma-
cia & Upjohn company, Germany) inside three different
wells soaked in one case with 3 ml of plain histoculture
medium and in the two other wells soaked in 3 ml of
histoculture medium containing recombinant human
TNF-α (R&D systems, Deutschland) in final concentra-
tions of 5 and 50 ng/ml respectively.
Luciferase activity quantification by luminometer or by ex 
vivo imaging system
Histocultures in the presence or absence of recombinant
human TNF-α were stopped after 48, 96, 120, 168 or 216
hours post-infection. All nine fragments on each sponge
were pooled inside a 14 ml round bottom tube containing
500 µl of lysis buffer (Promega, Madison USA) and
homogenised with a homogeniser (Ultraturax, X620 CAT
M-Zipperer GmbH, Germany). 100 µl of lysed tissue
supernatants was mixed with 100 µl of commercially
available substrate (Dual-Luciferase Reporter Assay Sys-
tem, Promega, Madison, USA) and then luciferase activity
read with a luminometer (Lumat LB 9501, Berthold) as
relative light units (RLU) per minute. For each type of
pseudotype (VSV-G, Ba-L, HXB2 or negative control), the
different doses of pseudotype and 3 to 4 different dura-
tions of histoculture were studied on the same placenta,
all without and with the two doses of TNF-α.
We adapted a complementary ex vivo imaging system,
(Xenogen IVIS100 and data analyzed by the Living Image
Software, Xenogen Corp., Alameda, CA, USA), to visualize
and measure the effect of TNF-α on HIV-1 replication in
the placenta. Placental fragments were left overnight in
contact with 2 ng of p24 antigen/fragment of VSV-G pseu-
dotyped HIV-1 or 20 ng of p24 antigen/fragment of delta-
Env pseudotyped HIV-1, then placed on collagen sponges
with 0 or 5 ng/ml of TNF-α for 120 hours. The fragments
were then collected and placed in contact with 1 µM luci-
ferine (Promega) for 4 hours at 37°C, then the biolumi-
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nescence of placental fragments was detected in the
Xenogen system and the photons per second from a con-
stant region of interest (ROI) were summed.
Statistical analysis
For each experimental condition, type and dose of pseu-
dotype and duration of histoculture, luciferase activity
was measured without and with 5 or 50 ng/ml of TNF-α
on three to seven different placentas from different
donors. Results of the luciferase activity without TNF-α
stimulation are presented globally as mean ± se. To take
into account the fact that the activities without and with
stimulation were evaluated on the same placentas, the
effect of each dose of pseudotype was expressed as the
ratio of the activity with each dose of TNF-α to the activity
without TNF-α in the same experimental condition, noted
ratio of infection, R. Then, for each type and dose of pseu-
dotype, these ratios were analysed through analysis of var-
iance using a factorial design including 2 factors, TNF-α
dose (5 or 50 ng/ml) and duration of histoculture (either
48, 96, 120 hours, or 120, 168, 216 hours), and 3 to 4 rep-
licates of placentas. For the duration of histoculture of 120
and 168 hours, 5 to 7 replicates were available for some
type of pseudotype. First, it was tested if TNF-α dose effect
varied with the duration of histoculture (interaction
between TNF-α dose and duration of histoculture). Sec-
ond, if no interaction was evidenced, the homogeneity of
TNF-α effect across doses was tested independently of the
duration of histoculture, whereas, in presence of interac-
tion, the homogeneity of TNF-α effect across doses was
tested for each duration of histoculture. Finally, the TNF-α dose effect was tested, either globally if homogeneity
was evidenced or for each dose otherwise, by comparing
the mean of the corresponding ratios to 1, using the resid-
ual error derived from the analysis of variance. The TNF-α
dose effect was expressed as the mean of the correspond-
ing ratios (mR) and its standard error (mR ± SE). There-
fore a mR of 4.0 for a given dose of TNF-α means that the
luciferase activity was multiplied on an average by 4 after
stimulation when compared to no stimulation.
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